Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This artificial peptide mimics the actions of naturally occurring GLP-1, a https://pr7bookmark.com/story21072022/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes